Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Anthony Harnden a Department of Primary Health Care, Institute of
Health Sciences, University of Oxford, Oxford OX3 7LF, b Department of Primary
Health Care, Imperial College of Science, Technology and Medicine,
London W2 1PG Correspondence to: A
Harnden anthony.harnden@dphpc.ox.ac.uk
| The first 150 words of the full text of this article appear below. |
Kawasaki disease is the leading cause of acquired heart
disease in children in the developed world and may be a risk factor for
adult ischaemic heart disease.1 A fifth of untreated
children develop cardiac lesions during the acute phase of the disease. The cause remains uncertain. Epidemiological studies support an infectious agent inducing the disease in a genetically susceptible minority. Superantigen toxins have been implicated. Reported incidence rates differ considerably throughout the developed world with rates in
Japan 10 times those in the United States and 30 times those in the
United Kingdom and Australia.2-4 Hospital surveillance data suggest the incidence of Kawasaki disease in Japan has risen by
over 50% between 1987 and 1998.2 To ascertain whether
there had been a similar rise in England, we investigated trends in hospital admissions for Kawasaki disease using routinely collected statistics from 1991 to 2000.
| |
Methods and results |
|---|
The hospital episode statistics database provides information on
every inpatient admission